Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) FCF Margin (2017 - 2025)

Arcus Biosciences (RCUS) has 9 years of FCF Margin data on record, last reported at 2713.33% in Q4 2025.

  • For Q4 2025, FCF Margin changed N/A year-over-year to 2713.33%; the TTM value through Dec 2025 reached 266.01%, changed N/A, while the annual FY2025 figure was 195.14%, 444514.0% down from the prior year.
  • FCF Margin reached 2713.33% in Q4 2025 per RCUS's latest filing, down from 475.0% in the prior quarter.
  • Across five years, FCF Margin topped out at 3627.78% in Q1 2022 and bottomed at 2713.33% in Q4 2025.
  • Average FCF Margin over 5 years is 219.02%, with a median of 244.02% recorded in 2022.
  • Peak YoY movement for FCF Margin: surged 436720bps in 2022, then tumbled -403578bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 23.5% in 2021, then plummeted by -810bps to 213.94% in 2022, then fell by -27bps to 270.97% in 2023, then surged by 87bps to 34.25% in 2024, then crashed by -7823bps to 2713.33% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 2713.33% in Q4 2025, 475.0% in Q1 2025, and 34.25% in Q3 2024.